Invex Therapeutics
(ASX) IXC
Invex Therapeutics Financials at a Glance
Market Cap
$6.76M
Revenue (TTM)
$1.44M
Net Income (TTM)
$722.02K
EPS (TTM)
$-0.01
P/E Ratio
-8.11
Dividend
$0.00
Beta (Volatility)
0.33 (Low)
Dividend
$0.00
Beta (Volatility)
0.33 (Low)
Price
$0.09
Volume
24,787
Open
$0.09
Price
$0.09
Volume
24,787
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.07 - $0.18
Dividend
$0.00
Beta (Volatility)
0.33 (Low)
Price
$0.09
Volume
24,787
Open
$0.09
Previous Close
$0.09
Daily Range
$0.09 - $0.09
52-Week Range
$0.07 - $0.18
IXC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Invex Therapeutics
Industry
Pharmaceuticals
Sector
Health CareWebsite
www.invextherapeutics.comHeadquarters
Perth, WA 6008, AU
IXC Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-17%
Return on Capital
-24%
Return on Assets
-18%
Earnings Yield
-12.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.76M
Shares Outstanding
75.15M
Volume
24.79K
Short Interest
0.00%
Avg. Volume
27.21K
Financials (TTM)
Gross Profit
$229.08K
Operating Income
$709.30K
EBITDA
$0.00
Operating Cash Flow
$652.57K
Capital Expenditure
$0.00
Free Cash Flow
$652.57K
Cash & ST Invst.
$5.38M
Total Debt
$0.00
Invex Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$6.76M
N/A
Market Cap/Employee
$1.69M
N/A
Employees
4
N/A
Net Income
$715.58K
+66.1%
EBITDA
$843.02K
-323.8%
Quarterly Fundamentals
Net Cash
$4.60M
-25.3%
Accounts Receivable
$128.00K
-0.5%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-17.70%
N/A
Return on Invested Capital
-23.76%
N/A
Free Cash Flow
$410.96K
+86.1%
Operating Cash Flow
$410.96K
+86.1%